Importantly, tumour MMAE concentrations from CAL-27 xenografts injected with C-MMAE or T-MMAE confirmed restriction of released drug to EGFR+ cells by cetuximab conjugation as opposed to trastuzumab conjugation (Fig. 4e). Here, EGFR is linked to neoplasm.